• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of regulatory molecule in platelets for thrombosis employing CMK cell system

Research Project

Project/Area Number 24591422
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Hematology
Research InstitutionOsaka University

Principal Investigator

TOMIYAMA Yoshiaki  大阪大学, 医学部附属病院, 准教授 (80252667)

Co-Investigator(Kenkyū-buntansha) KASHIWAGI Hirokazu  大阪大学, 大学院医学系研究科, 講師 (10432535)
TODOKORO Seiji  大阪大学, 大学院医学系研究科, 助教 (80403062)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
KeywordsインテグリンαIIbβ3 / CMK / inside-out signaling / talin-1 / kindlin-3 / 血小板 / タリン / キンドリン / Inside-out signaling / CMK細胞 / インテグリンαIIbβ3
Outline of Final Research Achievements

Platelet integrin αIIbβ3 plays a crucial role in thrombosis as well as hemostasis. In this study, we have investigated the regulatory mechanism for αIIbβ3 function employing novel CMK cell system.
We demonstrated that agonist stimulation, talin-1, and kindlin-3 were crucial for αIIbβ3 activation in CMK cells: overexpression of talin head domain is sufficient for the activation of αIIbβ3 exogenously expressed on CHO cells, but not for endogenous αIIbβ3 expressed on CMK cells in the absence of agonists.
In addition, employing several talin mutants, we strongly suggested that interaction between talin-1 and membrane proximal region of β3 plays a crucila role in αIIbβ3 activation.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (29 results)

All 2014 2013 2012 Other

All Journal Article (15 results) (of which Peer Reviewed: 12 results,  Open Access: 1 results,  Acknowledgement Compliant: 2 results) Presentation (13 results) (of which Invited: 5 results) Book (1 results)

  • [Journal Article] Eliminate dark side from antiplatelet therapy.2014

    • Author(s)
      Tomiyama Y
    • Journal Title

      Blood

      Volume: 123 Issue: 17 Pages: 2599-2601

    • DOI

      10.1182/blood-2014-03-560417

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy2014

    • Author(s)
      Kiyokawa, T. Koh, Y. Mimura, K. Nakayama, K. Hosokawa, M. Sakuragi, M. Morikawa, T. Nakao, M. Aochi, H. Fukumori, Y. Kanagawa, T. Nagamine, K. Kimura, T. Tomiyama, Y.
    • Journal Title

      Int J Hematol

      Volume: 100 Issue: 4 Pages: 398-401

    • DOI

      10.1007/s12185-014-1620-0

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] インテグリンαIIbβ3の構造変化と活性化:talinによる活性化機構.2014

    • Author(s)
      加藤 恒,冨山佳昭
    • Journal Title

      日本血栓止血学会誌

      Volume: 25 Pages: 619-628

    • NAID

      130004700441

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] 出血傾向の鑑別診断2014

    • Author(s)
      冨山佳昭
    • Journal Title

      内科

      Volume: 114 Pages: 193-197

    • Related Report
      2014 Annual Research Report
  • [Journal Article] Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.2013

    • Author(s)
      Kashiwagi H, Kunishima S, Kiyomizu K, Amano Y, Shimada H, Morishita M, Kanakura Y, Tomiyama Y.
    • Journal Title

      Mol Genet Genomic Med

      Volume: 1 Issue: 2 Pages: 77-86

    • DOI

      10.1002/mgg3.9

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Pathophysiology and management of primary immune thrombocytopenia.2013

    • Author(s)
      Kashiwagi H, Tomiyama Y.
    • Journal Title

      Int J Hematol

      Volume: 98 Issue: 1 Pages: 24-33

    • DOI

      10.1007/s12185-013-1370-4

    • NAID

      10031189594

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] The Integrin-Linked Kinase-PINCH-Parvin Complex Supports Integrin αIIbβ3 Activation2013

    • Author(s)
      Hond S, Shirotani-Ikejima H, Tadokoro S, Tomiyama Y, Miyata T
    • Journal Title

      PLOS ONE

      Volume: 8 Issue: 12 Pages: 1-13

    • DOI

      10.1371/journal.pone.0085498

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] インテグリン活性化とその制御~腫瘍細胞のコントロールにむけて.2013

    • Author(s)
      加藤 恒,冨山佳昭.
    • Journal Title

      日本血栓止血学会誌

      Volume: 24 Pages: 507-515

    • NAID

      130003384146

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Primary ITPにおける抗αIIbβ3自己抗体のエピトープ解析:抗αIIbβ3抗体はβプロペラドメイン内の高度に限定された領域を認識する.2013

    • Author(s)
      清水一亘, 柏木浩和, 冨山佳昭.
    • Journal Title

      日本血栓止血学会誌

      Volume: 24 Pages: 392-395

    • NAID

      130003367367

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Agonist stimulation, talin-1, and kindlin-3 are crucial for αIIbβ3 activation in a human megakaryoblastic cell line, CMK2013

    • Author(s)
      Nakazawa T, Tadokoro S, Kamae T, Kiyomizu K, Kashiwagi H, Honda S, Kanakura Y, Tomiyama Y.
    • Journal Title

      Exp Hematol.

      Volume: 41(1) Issue: 1 Pages: 79-90

    • DOI

      10.1016/j.exphem.2012.09.011

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia.2012

    • Author(s)
      Kiyomizu K, Kashiwagi H, Nakazawa T, Tadokoro S, Honda S, Kanakura Y, Tomiyama Y.
    • Journal Title

      Blood

      Volume: 120(7) Issue: 7 Pages: 1499-1509

    • DOI

      10.1182/blood-2012-02-409995

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages.2012

    • Author(s)
      Kodama T, Hikita H, Kawaguchi T, Shigekawa M, Shimizu S, Hayashi Y, Li W, Miyagi T, Hosui A, Tatsumi T, Kanto T, Hiramatsu N, Kiyomizu K, Tadokoro S, Tomiyama Y, Hayashi N, Takehara T.
    • Journal Title

      Cell Death Differ.

      Volume: 19(11) Issue: 11 Pages: 1856-1869

    • DOI

      10.1038/cdd.2012.88

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] P2Y12受容体に関する遺伝子関連検査.2012

    • Author(s)
      冨山佳昭.
    • Journal Title

      血栓止血誌

      Volume: 23 Pages: 450-456

    • NAID

      130002076999

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] 血栓止血系と分子標的.2012

    • Author(s)
      冨山佳昭,柏木浩和.
    • Journal Title

      日本臨牀

      Volume: 70(増刊) Pages: 263-267

    • Related Report
      2012 Research-status Report
  • [Journal Article] 血栓形成の分子機構; 血小板機能異常症の解析からみた最近の進歩.2012

    • Author(s)
      柏木浩和,冨山佳昭.
    • Journal Title

      Pharma Medica

      Volume: 30 Pages: 9-14

    • Related Report
      2012 Research-status Report
  • [Presentation] αIIb(R990W), a constitutive activating mutation of integrin αIIbβ3, knock-in mice show macrothrombocytopenia with impairment of platelet function2014

    • Author(s)
      Kiyomizu K, Kashiwagi H, Tomiyama Y, et al
    • Organizer
      The American Society of Hematology 56th Annual Meeting
    • Place of Presentation
      Moscone Center, San Francisco, USA
    • Year and Date
      2014-12-08
    • Related Report
      2014 Annual Research Report
  • [Presentation] Pathophysiology and management of ITP in Asia2014

    • Author(s)
      Tomiyama Y
    • Organizer
      The 8th Congress of Asian Pacific Society on Thrombosis and Hemostasis
    • Place of Presentation
      Convension Center, Hanoi, Vietnam
    • Year and Date
      2014-10-10
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] インテグリンαIIbβ3活性化変異、αIIb(R990W)ノックインマウスの解析2014

    • Author(s)
      清水一亘,柏木浩和,冨山佳昭, ら
    • Organizer
      第36回日本血栓止血学会学術集会
    • Place of Presentation
      大阪国際交流センター,大阪
    • Year and Date
      2014-05-31
    • Related Report
      2014 Annual Research Report
  • [Presentation] 血小板機能異常症の分子病態2014

    • Author(s)
      冨山佳昭
    • Organizer
      第36回日本血栓止血学会学術集会
    • Place of Presentation
      大阪国際交流センター,大阪
    • Year and Date
      2014-05-30
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] Autoantigenic epitopes on GPIIb-IIIa in ITP

    • Author(s)
      Tomiyama Y, Kiyomizu K, Kashiwagi H
    • Organizer
      The 24th Congress of the International Society on Thrombosis and Haemostasis
    • Place of Presentation
      Amsterdam, Netherland
    • Related Report
      2013 Research-status Report
  • [Presentation] αIIbβ3細胞内活性化変異と血小板顆粒放出異常

    • Author(s)
      柏木浩和,冨山佳昭ら
    • Organizer
      第35回日本血栓止血学会学術集会
    • Place of Presentation
      山形国際ホテル(山形県)
    • Related Report
      2013 Research-status Report
  • [Presentation] 腫瘍細胞インテグリンβ1活性化の転移における重要性

    • Author(s)
      加藤 恒,冨山佳昭ら
    • Organizer
      第35回日本血栓止血学会学術集会
    • Place of Presentation
      山形国際ホテル(山形県)
    • Related Report
      2013 Research-status Report
  • [Presentation] Pathophysiology and management of primary immune thrombocytopenia

    • Author(s)
      Tomiyama Y
    • Organizer
      The 17th Congress of the European Hematology Association
    • Place of Presentation
      Amsterdam RAI, The Netherlands
    • Related Report
      2012 Research-status Report
    • Invited
  • [Presentation] 新規薬剤による免疫性血小板減少症の治療

    • Author(s)
      冨山佳昭
    • Organizer
      第109回日本内科学会講演会
    • Place of Presentation
      みやこめっせ、京都
    • Related Report
      2012 Research-status Report
    • Invited
  • [Presentation] 難治性特発性血小板減少性紫斑病の治療

    • Author(s)
      冨山佳昭
    • Organizer
      第60回日本輸血・細胞治療学会総会
    • Place of Presentation
      ホテルハマス、福島
    • Related Report
      2012 Research-status Report
    • Invited
  • [Presentation] Pathophysiology and diagnosis of primary immune thrombocytopenia

    • Author(s)
      Tomiyama Y, et al.
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都国際会館、京都
    • Related Report
      2012 Research-status Report
  • [Presentation] Abnormal thrombopoiesis associated with integrin αIIbβ3 activating mutations

    • Author(s)
      柏木浩和, 冨山佳昭, ら
    • Organizer
      第34回日本血栓止血学会学術集会
    • Place of Presentation
      ハイアットリージェンシー東京、東京
    • Related Report
      2012 Research-status Report
  • [Presentation] ヒト巨核球系細胞株CMK におけるαIIbβ3 の活性化にはagonist,talin-1,kindlin-3 が必須である

    • Author(s)
      中澤剛士,冨山佳昭, ら
    • Organizer
      第34回日本血栓止血学会学術集会
    • Place of Presentation
      ハイアットリージェンシー東京、東京
    • Related Report
      2012 Research-status Report
  • [Book] よくわかる血栓・止血異常の診療2014

    • Author(s)
      柏木浩和,冨山佳昭
    • Total Pages
      13
    • Publisher
      中山書店
    • Related Report
      2014 Annual Research Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi